2022
DOI: 10.1016/j.cyto.2021.155761
|View full text |Cite
|
Sign up to set email alerts
|

Genetic association analysis between IL9 and coronary artery disease in a Chinese Han population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 43 publications
0
7
0
Order By: Relevance
“…CAD samples and control samples from UnionID were included in our study. The inclusion criteria for CAD samples were [16][17][18] as follows: (1) coronary angiography of the patient confirmed that at least one main vessel (left main artery, anterior descending branch, circumflex branch, or right coronary artery) was more than 70% narrowed; (2) the patient's history suggested that they had undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); and (3) the patient had a history of myocardial infarction (MI), and the criteria for MI were chest pain for more than half an hour, dynamic ECG changes, and enzymatic changes in levels of creatine kinase isoenzyme (CKMB) and troponin (TNI). Patients with coronary spasm, juvenile hypertension, type 1 diabetes, or congenital heart disease (CHD) were excluded.…”
Section: Study Populationmentioning
confidence: 99%
“…CAD samples and control samples from UnionID were included in our study. The inclusion criteria for CAD samples were [16][17][18] as follows: (1) coronary angiography of the patient confirmed that at least one main vessel (left main artery, anterior descending branch, circumflex branch, or right coronary artery) was more than 70% narrowed; (2) the patient's history suggested that they had undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); and (3) the patient had a history of myocardial infarction (MI), and the criteria for MI were chest pain for more than half an hour, dynamic ECG changes, and enzymatic changes in levels of creatine kinase isoenzyme (CKMB) and troponin (TNI). Patients with coronary spasm, juvenile hypertension, type 1 diabetes, or congenital heart disease (CHD) were excluded.…”
Section: Study Populationmentioning
confidence: 99%
“…IL12B gene located on chromosome 5q31, a region where we have previously identified multiple CHD susceptibility SNPs. 23,26,28 IL12B was related to lower risk of insulin resistance. However, Morahan et al 31 found rs2853694 was not susceptible to type 1 diabetes.…”
Section: Discussionmentioning
confidence: 91%
“…Of these, 768 CHDs and 768 controls were in the Phase I discovery study, and the remaining samples were used for further extended sample validation of single nucleotide polymorphism (SNP) that showed significant result in Phase I study (Figure 2). All of our samples have been obtained with DNA and relevant clinical information including: age, gender, height, weight, the history of smoking, drinking, hypertension and diabetes, blood lipid and fasting blood glucose, as well as other biochemical detection indicators information 23 . In addition, there are ECG, CT, heart colour ultrasound, coronary angiography and other imaging data of patients with CHD.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The expression of CCL18 [109], SLAMF7 [110], GPR174 [111], CCR4 [112], POU4F2 [113]. CCR2 [114], IL2RB [115], CCL4 [116], CCL24 [117], FASLG (Fas ligand) [118], CD24 [119], TDGF1 [120], CD28 [121], IL7R [122], CYP11B1 [123], CCL5 [124], CCL3 [125], LTF (lactotransferrin) [126], GPNMB (glycoprotein nmb) [127], CD209 [128], IL2RG [129], CHIT1 [130], TAB2 [131], CD163 [132], ALOX15B [133], NMRK2 [134], HGF (hepatocyte growth factor) [135], TRPM8 [136], DIO3 [137], SIGLEC1 [138], TTR (transthyretin) [139], IL24 [140], F13A1 [141], IL9 [142], VEGFA (vascular endothelial growth factor A) [143], RASAL1 [144], ADM (adrenomedullin) [145], ANGPTL4 [146], CHI3L1 [147], LDB3 [148], CNP (2’,3’-cyclic nucleotide 3’ phosphodiesterase) [149], HES6 [150], CMTM5 [151], PLXNB3 [152], KLK8 [153], CDKN1C [154], INSIG1 [155], GREM1 [156], ATF3 [157], HK2 [158], MCAM (melanoma cell adhesion molecule) [159], SEMA4D [160], GLUL (glutamate-ammonia ligase) [161], S1PR5 [162], FN3K [163], MEIS1 [164], ADAMTS4 [165], BIN1 [166], BMP2 [167], LMNA (lamin A/C) [168], ERBB3 [169], DLL1 [170], THBS2 [171], GADD45B [172], MYH6 [173]. PNPLA3 [174], ACTN2 [175], MMP15 [176], SVEP1 [177], CPB2 [178], DYSF (dysferlin) [179], ADAMTSL2 [180], NINJ2 [181], LRP2 [106], PHLDA3 […”
Section: Discussionmentioning
confidence: 99%